Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
FibroBiologics Chief Scientific Officer Hamid Khoja purchased 30,000 shares of common stock on March 4, 2026, for $0.38 per share, a $11,400 transaction that brings his direct ownership to 61,250 shares. The trade coincides with recent share-price gains and a string of corporate developments including a U.S. patent for an osteoporosis treatment, sh…
ChoiceOne Financial Services director Bradley F. McGinnis acquired 1,000 shares of the bank's common stock on March 3, 2026, in a Form 4 filing with the SEC. The purchase totaled $29,150 at $29.15 per share. The stock trades at $29.58, with a P/E of 14.76. InvestingPro identifies the company as undervalued and notes a 3.92% dividend yield and 33 co…
Anthony J. Kuczinski, a director at Skyward Specialty Insurance Group (NASDAQ: SKWD), purchased common stock in three open-market transactions totaling $239,464. The buys were executed between February 27 and March 3, 2026, and increase his direct ownership to 11,903 shares. The moves come as the stock trades near $48.65 and amid InvestingPro comme…
First National Corp (NASDAQ: FXNC) EVP and CFO Brad E. Schwartz purchased 1,000 shares on March 4, 2026, at $26.91 per share for a total of $26,910. The transaction occurred while the share price was trading near $26.76, below InvestingPro's Fair Value estimate of $30.26. The regional bank is trading at a P/E of 13.7 and yields 2.54% in dividends; …
American Bitcoin Corp director Justin Mateen bought 1,800,000 shares of Class A Common Stock on March 3, 2026, paying $1.03 per share for a total of $1,854,000, according to a Form 4 filed with the SEC. The purchase increased his direct holdings to 2,524,975 shares. The stock has since traded up to $1.15 but remains about 82% below its 52-week high…
American Bitcoin Corp. director Richard Busch bought a combined $333,900 of Class A common stock in two trades on March 3 and March 4, 2026. The purchases increased his direct stake to 1,330,975 shares. The transactions come as the share price hovers close to a 52-week low and after the company reported sequential revenue growth for Q4 2025 alongsi…
Aaron C. Von Staats, PTC Inc.'s Executive Vice President and Chief Legal Officer, sold 2,639 shares on March 3, 2026 under a pre-arranged 10b5-1 trading plan, netting $422,240. The company reported stronger-than-expected Q1 fiscal 2026 results with EPS of $1.92 and revenue of $686 million, and continues product development with a Model-Based Defini…
Equinix Chief Customer & Revenue Officer Michael Shane Paladin sold 156 shares of Equinix common stock on March 3, 2026, bringing total proceeds to $198,665. The transaction followed an exercise of restricted stock units on March 2, 2026 in which Paladin received 510 shares at a $0 exercise price. The moves come as Equinix and CPP Investments agree…
Datadog Chief Executive Officer Olivier Pomel sold 68,922 shares of Class A common stock on March 2, 2026, for roughly $7.6 million. The sale, executed at prices between $110.53 and $111.73 per share, was used to meet tax withholding obligations tied to vested restricted stock units and performance-based restricted stock units, plus brokerage commi…
Datadog Chief Operating Officer Adam Blitzer executed two separate blocks of Class A common stock sales in early March 2026 totaling 61,921 shares and proceeds of about $7.23 million. The transactions occurred while Datadog shares trade substantially below their 52-week peak, and follow recent corporate developments including a board appointment, a…
Datadog Inc.'s Chief Revenue Officer, Sean Michael Walters, sold 32,118 shares of Class A common stock on March 2, 2026, for about $3.5 million to meet tax and commission obligations tied to vesting restricted stock awards. The transaction was disclosed on a Form 4 filed March 4, 2026. Separately, Datadog named Dominic Phillips to its board and ent…
Edward G. Canup, Chief Banking Officer of Colony Bankcorp Inc (NASDAQ: CBAN), purchased 1,000 shares of the company's common stock on February 27, 2026, paying $20.25 for 500 shares and $20.00 for another 500 shares, for a total outlay of $20,125. The filings show Canup now directly holds 27,156.12 shares and indirectly holds 8,199.53 shares throug…
10x Genomics Chief Executive Officer Serge Saxonov sold 16,152 shares of Class A common stock on March 2, 2026, in two tranches that generated roughly $367,096 in proceeds. The transactions occurred as the stock traded close to a 52-week peak and following the company’s fourth-quarter 2025 earnings beat and subsequent analyst price-target increases…
Isabella Bank Corp's Chief Credit Officer, Jon D. Catlin, purchased 103 shares on March 2, 2026, at $31.47 apiece, a $3,241 transaction. The company's shares have climbed to $47.80, a 106% gain over the past year. The bank also declared a first-quarter cash dividend, announced a new chief financial officer and saw Piper Sandler raise its price targ…
Mark C. Rodgers, Newmont's Managing Director for Africa-Asia Pacific, sold 1,361 shares on March 3, 2026, for $120.78 per share under a pre-established Rule 10b5-1 plan. Following the trade, Rodgers retains 25,756 shares. The sale occurred while Newmont shares traded at $119.37 and as the company is navigating analyst revisions, production forecast…
James S. Abernethy, a director of Peoples Bancorp of North Carolina Inc (PEBK), sold 477 shares on March 3, 2026, for $37.60 per share, netting $17,935. The transaction leaves him with substantial direct and indirect ownership. Separately, the bank announced a $0.17 per share special cash dividend with a February 4, 2026 record date and a February …
James S. Abernethy, a director at Peoples Bancorp of North Carolina Inc (NASDAQ: PEBK), sold 477 shares on March 3, 2026, for $37.60 each, totaling $17,935. The stock is trading at $38.41, roughly 50% higher over the past year, while third-party analysis indicates shares may be overvalued versus fair value. The company also announced a special cash…
Mark C. Rodgers, MD, Newmont’s Africa-Asia Pacific executive, sold 1,361 shares on March 3, 2026 for $120.78 each, netting $164,381. The transaction occurred under a Rule 10b5-1 plan and follows a 176% year-over-year rally in Newmont shares. Analysts’ views vary from bullish upgrades to cautious targets as the company navigates production declines,…
Honest Company Chief Innovation Officer Stephen Winchell reported the sale of 73,685 shares on March 3, 2026, per a Form 4 filing. The transaction totaled $209,265 at a weighted average price of $2.84. After the sale Winchell directly holds 517,466 shares, including 444,422 restricted stock units. The stock has traded up to $2.93 recently. The comp…
Joseph W. LaPlume, Executive Vice President of Corporate Strategy & Development at Charles River Laboratories International Inc (NYSE: CRL), purchased 25 shares on March 3, 2026, for $174.54 each, a transaction valued at $4,363. The company recently reported fourth-quarter 2025 results that exceeded analyst expectations and disclosed plans to dives…
Catherine T. Doherty, Executive Vice President at Quest Diagnostics (DGX), completed two separate stock disposals on March 2 and March 3, 2026. One sale on March 3 involved 632 shares at $207.73 worth $131,285. A March 2 disposal of 648 shares at $204.86, totaling $132,749, was executed to cover tax obligations tied to vesting restricted share unit…
Verisign Executive Vice President, General Counsel and Secretary Thomas C. Indelicarto sold 498 shares of Verisign stock on March 3, 2026, across two trades that generated $115,426. The filing records his post-sale holdings and recent dividend-equivalent restricted stock units; the company reported mixed fourth-quarter 2025 results and trades at a …
NeuroPace Inc.'s Chief Medical Officer, Martha Morrell, executed a pre-arranged sale of 25,000 shares on December 15, 2025, realizing $399,250. Subsequent withholding of 1,340 vested restricted shares occurred on March 3, 2026 to cover tax obligations. The company reported fourth-quarter 2025 results that beat analyst forecasts on both EPS and reve…
Amy Parison, senior vice president and chief financial officer of Editas Medicine, sold 474 shares of the company’s common stock on March 3, 2026, under a pre-arranged automatic sales plan established in 2022 to meet tax obligations arising from restricted stock units that vested on March 2, 2026. The trade, reported on a Form 4 filing, totaled $95…
Pedro J. Lopez-Baldrich, Chief Legal Officer of SharkNinja, sold 24,099 ordinary shares on March 3, 2026, in multiple transactions under a Rule 10b-5 trading plan. The disposals totaled $2,775,261 at prices between $113.64 and $116.37. SharkNinja is valued at $16.2 billion and recent quarterly results showed adjusted sales growth of 17.6%, with adj…
